{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-077296","form_type":"8-K","ticker":"SILO","cik":"0001514183","company_name":"Silo Pharma, Inc.","filed_at":"2026-07-10T22:29:27+00:00","discovered_at":"2026-07-13T10:05:00.256954+00:00","generated_at":"2026-07-13T10:05:38.754262+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Silo Pharma raises $4M in private placement; warrants could add $7.7M","bullets":["Issued 619,965 shares (or pre-funded warrants) at $6.452/share plus Series A-3 and A-4 warrants.","Warrants exercisable at $6.21/share; Series A-3 expire 5 years, Series A-4 expire 18 months after registration.","Net proceeds expected ~$3.5M after fees; H.C. Wainwright acted as placement agent.","Proceeds to be used for working capital and general corporate purposes.","Potential additional $7.7M if all warrants exercised for cash; no assurance of exercise."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-077296","json":"https://secwatch.observer/filing/0001213900-26-077296.json","markdown":"https://secwatch.observer/filing/0001213900-26-077296.md","text":"https://secwatch.observer/filing/0001213900-26-077296.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1514183/000121390026077296/0001213900-26-077296-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1514183/000121390026077296/ea0297602-8k_silo.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-13T10:05:38.754262+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}